• 1. An approach for correlating the structural and electrical properties of Zr4+-modified SrBi4Ti4O15/SBT ceramic
  Priyambada Nayak,Tanmaya Badapanda,Anil Kumar Singh,Simanchalo Panigrahi RSC Adv., 2017,7, 16319-16331
• 2. An amorphous lanthanum–iridium solid solution with an open structure for efficient water splitting?
  Wei Sun,Chenglong Ma,Xinlong Tian,Jianjun Liao,Ji Yang,Chengjun Ge,Weiwei Huang J. Mater. Chem. A, 2020,8, 12518-12525
• 3. An aptasensor for the detection of ampicillin in milk using a personal glucose meter
  Xixi Li,Nanwei Zhu,Ruohan Li,Qinpu Zhang Anal. Methods, 2020,12, 3376-3381
• 4. An artificial enzyme cascade amplification strategy for highly sensitive and specific detection of breast cancer-derived exosomes?
  Huiying Xu,Lu Zheng,Yu Zhou,Bang-Ce Ye Analyst, 2021,146, 5542-5549
• 5. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642

Introduction to 5-bromo-4-chloro-2-(1-methylcyclopropyl)pyrimidine (CAS No. 1513097-54-5)

5-bromo-4-chloro-2-(1-methylcyclopropyl)pyrimidine, identified by its CAS number 1513097-54-5, is a significant compound in the realm of pharmaceutical and agrochemical research. This heterocyclic aromatic molecule features a pyrimidine core substituted with bromine, chlorine, and a unique 1-methylcyclopropyl side chain. The structural configuration of this compound imparts distinct chemical properties that make it a valuable intermediate in synthetic chemistry, particularly in the development of novel bioactive molecules.

The pyrimidine scaffold is a cornerstone in medicinal chemistry due to its prevalence in nucleoside analogs and other pharmacologically relevant structures. The presence of both bromo and chloro substituents on the pyrimidine ring enhances its reactivity, making it a versatile precursor for further functionalization. This reactivity is particularly exploited in cross-coupling reactions, such as Suzuki-Miyaura and Buchwald-Hartwig couplings, which are pivotal in constructing complex molecular architectures.

The 1-methylcyclopropyl moiety appended to the pyrimidine ring introduces steric and electronic modifications that can influence the compound's biological activity. This substituent has been increasingly studied for its potential in modulating receptor interactions and metabolic stability. Recent advancements in computational chemistry have highlighted the role of such structural features in optimizing drug-like properties, including solubility, permeability, and binding affinity.

In the context of contemporary pharmaceutical research, 5-bromo-4-chloro-2-(1-methylcyclopropyl)pyrimidine has garnered attention for its utility in designing kinase inhibitors. Kinases are critical targets in oncology and inflammatory diseases, and pyrimidine-based inhibitors have shown considerable promise in clinical trials. The bromo and chloro substituents facilitate palladium-catalyzed cross-coupling reactions to introduce aryl or heteroaryl groups, which are often essential for high-affinity binding to kinase active sites.

Recent studies have demonstrated the compound's efficacy as a building block for developing small-molecule modulators of protein-protein interactions. The unique combination of electronic and steric properties provided by the 1-methylcyclopropyl group allows for fine-tuning of interactions with target proteins. This has been particularly relevant in the pursuit of inhibitors targeting protein-protein interfaces, which are challenging but crucial for addressing complex diseases.

The agrochemical sector has also explored derivatives of 5-bromo-4-chloro-2-(1-methylcyclopropyl)pyrimidine for their potential as herbicides or fungicides. The structural motifs present in this compound contribute to its ability to interfere with essential enzymatic pathways in plants and fungi. For instance, modifications at the bromo and chloro positions can alter the spectrum of biological activity, enabling the design of compounds with enhanced selectivity or potency.

From a synthetic chemistry perspective, the preparation of 5-bromo-4-chloro-2-(1-methylcyclopropyl)pyrimidine exemplifies modern methodologies in heterocyclic synthesis. The synthesis typically involves multi-step sequences starting from readily available precursors, employing transition metal catalysis and orthogonal functional group transformations. Advances in flow chemistry have further streamlined the preparation of this compound, allowing for scalable production under controlled conditions.

The compound's stability under various storage conditions is another critical consideration. Proper handling and storage protocols are essential to maintain its integrity during both laboratory-scale synthesis and industrial production. Analytical techniques such as nuclear magnetic resonance (NMR), mass spectrometry (MS), and high-performance liquid chromatography (HPLC) are routinely employed to confirm purity and structural integrity.

Future directions in research involving 5-bromo-4-chloro-2-(1-methylcyclopropyl)pyrimidine may explore its role in developing next-generation therapeutics. The integration of machine learning models into drug discovery pipelines has identified this compound as a promising scaffold for further optimization. By leveraging computational predictions alongside experimental validation, researchers aim to accelerate the development of novel bioactive molecules derived from this structure.

In summary, 5-bromo-4-chloro-2-(1-methylcyclopropyl)pyrimidine (CAS No. 1513097-54-5) represents a versatile intermediate with broad applications across pharmaceuticals and agrochemicals. Its unique structural features—comprising a pyrimidine core substituted with bromine, chlorine, and a 1-methylcyclopropyl side chain—make it a valuable tool for synthetic chemists and biologists alike. As research continues to uncover new methodologies and applications, this compound is poised to remain at the forefront of molecular innovation.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)